AXSOME THERAPEUTICS, INC. (AXSM) Operating cash flow 2016–2025
AXSOME THERAPEUTICS, INC. (AXSM) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$93.4MFY2025 · since FY2016: -$21.3M → -$93.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$93.4M | +27.3% |
| FY2024 | -$128.4M | +11.5% |
| FY2023 | -$145.1M | -24.5% |
| FY2022 | -$116.5M | -7.7% |
| FY2021 | -$108.2M | -37.9% |
| FY2020 | -$78.5M | -69.2% |
| FY2019 | -$46.4M | -54.3% |
| FY2018 | -$30.1M | -13.5% |
| FY2017 | -$26.5M | -24.4% |
| FY2016 | -$21.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice